| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 139 |
| 1 | PREDNISONE | 128 |
| 2 | METHOTREXATE | 125 |
| 3 | TACROLIMUS | 101 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 91 |
| 5 | TACROLIMUS OINTMENT 0.1% | 91 |
| 6 | MYCOPHENOLATE MOFETIL | 70 |
| 7 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 70 |
| 8 | ADALIMUMAB | 67 |
| 9 | RITUXIMAB | 63 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RETIFANLIMAB-DLWR | 1 | 0.0139 |
| 1 | BENZETHONIUM CHLORIDE | 1 | 0.0078 |
| 2 | TALIMOGENE LAHERPAREPVEC | 11 | 0.0069 |
| 3 | AVELUMAB | 12 | 0.0029 |
| 4 | BENZALKONIUM CHLORIDE 0.13% | 1 | 0.0027 |
| 5 | ALDESLEUKIN | 3 | 0.0024 |
| 6 | BENZALKONIUM CHLORIDE | 1 | 0.0023 |
| 7 | CALAMINE | 1 | 0.0023 |
| 8 | FERRIC OXIDE RED | 1 | 0.0022 |
| 9 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 16 | 0.0020 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 197 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 142 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 125 |
| 3 | Kinase Inhibitor [EPC] | 102 |
| 4 | Janus Kinase Inhibitor [EPC] | 75 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 74 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 63 |
| 7 | Alkylating Drug [EPC] | 46 |
| 8 | Purine Antimetabolite [EPC] | 40 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 39 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Lymphocyte Growth Factor [EPC] | 3 | 0.0024 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 6 | 0.0010 |
| 3 | Provitamin D2 Compound [EPC] | 25 | 0.0008 |
| 4 | Sulfonamide Antibacterial [EPC] | 3 | 0.0008 |
| 5 | Interleukin-1 Receptor Antagonist [EPC] | 10 | 0.0006 |
| 6 | Antimetabolite Immunosuppressant [EPC] | 12 | 0.0006 |
| 7 | Programmed Death Ligand-1 Blocker [EPC] | 12 | 0.0006 |
| 8 | Cannabinoid [EPC] | 4 | 0.0005 |
| 9 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |